购物车
0
有库存
HIT212713763
 sdf 文件
结构编辑
类似物检索
HIT212713763
  • HIT ID:HIT212713763
  • Cas No:209746-56-5
  • 常用名:T-1095A
  • 别名:T 1095A, J1.265.331J
  • IUPAC:3-(1-benzofuran-5-yl)-1-(2-hydroxy-4-methyl-6-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)propan-1-one
    IUPAC:3-(1-benzofuran-5-yl)-1-(2-hydroxy-4-methyl-6-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)propan-1-one
  • InChI key:GMYFQAHYWIYNES-PFKOEMKTSA-N
  • 分子式:C24H26O9
  • 分子量:458.463
  • 氢键供体数 (HBD):5
  • 氢键受体数 (HBA):8
  • LogP:2.2571478
  • SMILES:Cc1cc(O)c(C(=O)CCc2ccc3occc3c2)c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c1
    SMILES:Cc1cc(O)c(C(=O)CCc2ccc3occc3c2)c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c1
  • T-1095A is an active metabolite of T-1095, a potent and selective inhibitor of Na+-glucose cotransporters (SGLTs). Chronic administration of T-1095 (0.1% w w(-1) pellet chow, for 12 weeks) decreased blood glucose and haemoglobin A(1C) levels, and improved glucose intolerance in db/db mice. Long-term treatment with T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats.
市场产品/服务共显示1个结果
  • 供应商
    TargetMolSC
    规格
    货期
    6-8周
    纯度
    -
    ¥ 10,600.00
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~